ライフサイエンスコーパス: breast conservation therapy

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 al surgical resection has been supplanted by breast conservation therapy.

2 mph node-negative breast cancer treated with breast-conservation therapy.

3 Breast conservation therapy after neoadjuvant chemothera

4 n, data from a previously published study of breast conservation therapy among women of Ashkenazi des

5 s were selected, including 8108 who received breast conservation therapy and 13,488 who received mast

6 sfaction was similar between those receiving breast conservation therapy and those receiving mastecto

7 ts, 11 underwent mastectomy, seven underwent breast-conservation therapy, and one did not undergo a s

8 r some women to be successfully treated with breast conservation therapy (BCT ) who were initially co

9 We investigated rates of radiation use after breast conservation therapy (BCT) for patients treated f

10 s done to determine the long-term outcome of breast conservation therapy (BCT) for patients with earl

11 studies that directly compare survival after breast conservation therapy (BCT) vs mastectomy.

12 7 patients with biopsy-proven ILC undergoing breast-conservation therapy (BCT) at the University of V

13 Whole-breast irradiation, as part of breast-conservation therapy (BCT), has well-established

14 TNBC is not a contraindication for breast conservation therapy because data suggest increas

15 Review of special issues in breast conservation therapy demonstrates no benefit to e

16 The long-term efficacy of breast conservation therapy for early breast cancer cont

17 In local recurrence after breast-conservation therapy for DCIS, histopathologic fi

18 al of 447 (7.9%) of 5660 patients undergoing breast-conservation therapy from 1970 to 2005 experience

19 After breast-conservation therapy, IBTR may be classified into

20 Breast conservation therapy, mastectomy alone, or mastec

21 d be obtained in patients who have undergone breast conservation therapy only when considered necessa

22 ce risks (relative to luminal subtypes) with breast conservation therapy or mastectomy.

23 om re-excision to mastectomy (n = 3) or from breast-conservation therapy to mastectomy (n = 1).

24 Breast conservation therapy was performed in 310 cases i

25 Breast conservation therapy was used to treat 70% of pat

26 26 patients with 27 local recurrences after breast-conservation therapy were identified.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。